| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/29/2005 | CA2562388A1 Emulsion-stabilized preparation |
| 09/29/2005 | CA2560767A1 Novel crystal of triterpene derivative |
| 09/29/2005 | CA2560286A1 Substituted quinazoline or pyridopyrimidine derivative |
| 09/29/2005 | CA2560157A1 New quaternized quinuclidine esters |
| 09/29/2005 | CA2559646A1 Medicine for prevention or treatment of frequent urination or urinary incontinence |
| 09/29/2005 | CA2559211A1 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 09/29/2005 | CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols |
| 09/29/2005 | CA2558020A1 Use of renin inhibitors in therapy |
| 09/28/2005 | EP1580266A1 Screening method |
| 09/28/2005 | EP1580192A2 16-Hydroxyestratrienes as selective estrogens |
| 09/28/2005 | EP1579866A1 Novel use of edg receptors |
| 09/28/2005 | EP1578926A2 Novel prostate tumor-specific promoter |
| 09/28/2005 | EP1578914A2 Human ion channels |
| 09/28/2005 | EP1578787A1 Novel chi-conotoxin peptides (-ii) |
| 09/28/2005 | EP1578418A2 Use of substituted 2,5-diamidoindoles for the treatment of urological diseases |
| 09/28/2005 | EP1578360A2 Conjoint administration of morphogens and ace inhibitors in treatment of chronic renal failure |
| 09/28/2005 | EP1463731B1 Dibenzodiazepine derivates, their preparation and use |
| 09/28/2005 | EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 09/28/2005 | EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 09/28/2005 | EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 09/28/2005 | EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 09/28/2005 | EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 09/28/2005 | EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
| 09/28/2005 | EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 09/28/2005 | CN1675233A Process for selective production of aryl 5-thio-beta-d-aldohexopyranosides |
| 09/28/2005 | CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/28/2005 | CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675180A Indole, indazole, and benzazole derivative |
| 09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674937A Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674907A Use of reboxetine for the treatment of hot flashes |
| 09/28/2005 | CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| 09/28/2005 | CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1672711A Urotoxin eliminating capsule and its prepn |
| 09/28/2005 | CN1672710A Urotoxin eliminating effervescent tablet and its prepn |
| 09/28/2005 | CN1672709A Urotoxin eliminating tablet and its prepn |
| 09/28/2005 | CN1672708A Dispersive tablet for treating heat-type stranguria and its prepn |
| 09/28/2005 | CN1672678A Separation and extraction of natural active long-chain fatty acid component for preventing and treating prostatosis and the prepn and application of its medicine prepn |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220519C Chinese medicinal composition for treating prostate cancer, its preparation method and its application in the preparation |
| 09/28/2005 | CN1220487C Composite amino acid composition for kidney protection and its use |
| 09/27/2005 | US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 09/27/2005 | US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 09/27/2005 | US6949566 For use as metalloproteinase inhibitors |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949555 Use of organic compounds |
| 09/27/2005 | US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 09/27/2005 | US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF |
| 09/22/2005 | WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |
| 09/22/2005 | WO2005087749A1 2-aminoquinazoline derivative |
| 09/22/2005 | WO2005087267A1 Remedies for prostatic hypertrophy |
| 09/22/2005 | WO2005087245A1 TESTOSTERONE 5α-REDUCTASE INHIBITOR |
| 09/22/2005 | WO2005025503A3 A composition and method of treatment for urogenital conditions |
| 09/22/2005 | US20050209341 R-(-)-N-methyl 3-((2-methyl-4-hydroxyphenyl)oxy)-3-phenyl-1-aminopropane or its hydrochloride salt; inhibiting the uptake of norepinephrine and serotonin; antidepressants, analgesics; treating sleep disorders, autism, psychological disorders, eating disorders |
| 09/22/2005 | US20050209329 Potentiation of therapeutic effects of fatty acids |
| 09/22/2005 | US20050209309 Aryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same |
| 09/22/2005 | US20050209272 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/22/2005 | US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/22/2005 | US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline |
| 09/22/2005 | US20050209188 Methods using glycosaminoglycans for the treatment of nephropathy |
| 09/22/2005 | US20050209169 Respiratory disorders such as pulmonary emphysema, acute respiratory distress syndrome, shock lung, cystic fibrosis (mucoviscidosis), chronic bronchitis, glomerulonephritis and rheumatoid arthritis |
| 09/22/2005 | US20050209128 Statins, especially (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid, as nerve conduction velocity or nerve blood flow enhancers in combination with an aldose reductase inhibitor, an ACE inhibitor or an Angiotensin II antagonist |
| 09/22/2005 | US20050208605 An antibody or fragment (especially a monoclonal antibody) that binds to specific antigens for use in the diagnosis and treatment of heart, kidney and inflammatory diseases |
| 09/22/2005 | US20050208197 Agonists/antagonists of muscarine M3 receptors, obtained from beer through isolation and purification; distillation; chromatography; side effect reduction |
| 09/22/2005 | US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture |
| 09/22/2005 | US20050208129 Prolonged release bioadhesive therapeutic systems |
| 09/22/2005 | US20050208001 rosacea, intrinsic or chronological aging, pigmentation, seborrhoeic function, barrier function, epidermal lipid secretion, wound healing, atrophies, ulcers, immune system, cardiovascular system disorders; 6-(5,6,7,8-tetrahydro-5,5,8,8-tetra-methylnaphthalene-2-carbonyl)naphthalene-2-carboxylic acid |
| 09/22/2005 | CA2560098A1 2-aminoquinazoline derivative |
| 09/21/2005 | EP1577323A1 Metastin derivative and use thereof |
| 09/21/2005 | EP1577309A1 Optically active dihydropyridine derivative |
| 09/21/2005 | EP1576964A1 Protease inhibitor |
| 09/21/2005 | EP1576959A1 A coixenolide capsules for treating prostate disease |
| 09/21/2005 | EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines |
| 09/21/2005 | EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use |
| 09/21/2005 | EP1576090A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/21/2005 | EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2005 | EP1575585A1 Pharmaceutical liquid composition containing pyridone derivative |
| 09/21/2005 | EP1575499A2 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 09/21/2005 | EP1575480A2 Compositions and methods for the treatment of immune related diseases |
| 09/21/2005 | EP1377560B1 Piperazine derivatives as tachykinin antagonists |
| 09/21/2005 | EP1355641B1 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
| 09/21/2005 | EP1339694B1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 09/21/2005 | EP1303501B1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 09/21/2005 | EP1294679B1 Beta-amino acid nitrile derivatives |
| 09/21/2005 | CN1671837A Neutralizing human anti-IGFR antibody |
| 09/21/2005 | CN1671730A Oligonucleotide-containing pharmacological compositions and their use |
| 09/21/2005 | CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 09/21/2005 | CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/21/2005 | CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/21/2005 | CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors |
| 09/21/2005 | CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im |